Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2000 Sep;83(3):220–222. doi: 10.1136/adc.83.3.220

Idiopathic thrombocytopenic purpura

P Bolton-Maggs
PMCID: PMC1718449  PMID: 10952638

Abstract

Idiopathic thrombocytopenic purpura in children usually a self limiting disorder. It may follow a viral infection or immunisation and is caused by an inappropriate response of the immune system. About 20-30% of children will fail to remit over six months (chronic idiopathic thrombocytopenic purpura). This is more likely in older children, especially girls. The disease is reviewed with reference to diagnosis, investigation, and management options.



Full Text

The Full Text of this article is available as a PDF (67.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanchette V., Imbach P., Andrew M., Adams M., McMillan J., Wang E., Milner R., Ali K., Barnard D., Bernstein M. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet. 1994 Sep 10;344(8924):703–707. doi: 10.1016/s0140-6736(94)92205-5. [DOI] [PubMed] [Google Scholar]
  2. Bolton-Maggs P. H., Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 1997 Aug 30;350(9078):620–623. doi: 10.1016/s0140-6736(97)04143-3. [DOI] [PubMed] [Google Scholar]
  3. Calpin C., Dick P., Poon A., Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med. 1998 Apr;152(4):345–347. doi: 10.1001/archpedi.152.4.345. [DOI] [PubMed] [Google Scholar]
  4. Carcao M. D., Zipursky A., Butchart S., Leaker M., Blanchette V. S. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998 Jun;424:71–74. doi: 10.1111/j.1651-2227.1998.tb01239.x. [DOI] [PubMed] [Google Scholar]
  5. Chessells J. Chronic idiopathic thrombocytopenic purpura: primum non nocere. Arch Dis Child. 1989 Sep;64(9):1326–1328. doi: 10.1136/adc.64.9.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Donnér M., Holmberg L., Nilsson I. M. Type IIB von Willebrand's disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancy. Br J Haematol. 1987 Jul;66(3):349–354. doi: 10.1111/j.1365-2141.1987.tb06922.x. [DOI] [PubMed] [Google Scholar]
  7. Eden O. B., Lilleyman J. S. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child. 1992 Aug;67(8):1056–1058. doi: 10.1136/adc.67.8.1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gaines A. R. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood. 2000 Apr 15;95(8):2523–2529. [PubMed] [Google Scholar]
  9. George J. N., Woolf S. H., Raskob G. E., Wasser J. S., Aledort L. M., Ballem P. J., Blanchette V. S., Bussel J. B., Cines D. B., Kelton J. G. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 1;88(1):3–40. [PubMed] [Google Scholar]
  10. Halperin D. S., Doyle J. J. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child. 1988 May;142(5):508–511. doi: 10.1001/archpedi.1988.02150050046027. [DOI] [PubMed] [Google Scholar]
  11. Imbach P., Wagner H. P., Berchtold W., Gaedicke G., Hirt A., Joller P., Mueller-Eckhardt C., Müller B., Rossi E., Barandun S. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet. 1985 Aug 31;2(8453):464–468. doi: 10.1016/s0140-6736(85)90400-3. [DOI] [PubMed] [Google Scholar]
  12. Lilleyman J. S. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child. 1994 Sep;71(3):251–253. doi: 10.1136/adc.71.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lilleyman J. S. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol. 1999 Jun;105(4):871–875. [PubMed] [Google Scholar]
  14. Manco-Johnson M. J., Nuss R., Key N., Moertel C., Jacobson L., Meech S., Weinberg A., Lefkowitz J. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr. 1996 Mar;128(3):319–323. doi: 10.1016/s0022-3476(96)70274-3. [DOI] [PubMed] [Google Scholar]
  15. Medeiros D., Buchanan G. R. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. J Pediatr. 1998 Sep;133(3):334–339. doi: 10.1016/s0022-3476(98)70265-3. [DOI] [PubMed] [Google Scholar]
  16. Najean Y., Rain J. D., Billotey C. The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies. Br J Haematol. 1997 Jun;97(3):547–550. doi: 10.1046/j.1365-2141.1997.832723.x. [DOI] [PubMed] [Google Scholar]
  17. Reid M. M. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child. 1995 Feb;72(2):125–128. doi: 10.1136/adc.72.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tamary H., Kaplinsky C., Levy I., Cohen I. J., Yaniv I., Stark B., Goshen Y., Zaizov R. Chronic childhood idiopathic thrombocytopenia purpura: long-term follow-up. Acta Paediatr. 1994 Sep;83(9):931–934. doi: 10.1111/j.1651-2227.1994.tb13175.x. [DOI] [PubMed] [Google Scholar]
  19. Tarantino M. D., Madden R. M., Fennewald D. L., Patel C. C., Bertolone S. J. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr. 1999 Jan;134(1):21–26. doi: 10.1016/s0022-3476(99)70367-7. [DOI] [PubMed] [Google Scholar]
  20. Taub J. W., Warrier I., Holtkamp C., Beardsley D. S., Lusher J. M. Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol. 1995 Feb;48(2):104–107. doi: 10.1002/ajh.2830480207. [DOI] [PubMed] [Google Scholar]
  21. Vesely S., Buchanan G. R., Cohen A., Raskob G., George J. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol. 2000 Jan-Feb;22(1):55–61. doi: 10.1097/00043426-200001000-00011. [DOI] [PubMed] [Google Scholar]
  22. Waghorn D. J., Mayon-White R. T. A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed? J Infect. 1997 Nov;35(3):289–294. doi: 10.1016/s0163-4453(97)93232-1. [DOI] [PubMed] [Google Scholar]
  23. Warrier I., Bussel J. B., Valdez L., Barbosa J., Beardsley D. S. Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group. J Pediatr Hematol Oncol. 1997 May-Jun;19(3):197–201. doi: 10.1097/00043426-199705000-00004. [DOI] [PubMed] [Google Scholar]
  24. Zipursky A., Poon A., Doyle J. Leukemia in Down syndrome: a review. Pediatr Hematol Oncol. 1992 Apr-Jun;9(2):139–149. doi: 10.3109/08880019209018329. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES